Daily Briefing – April 22: Markets are trying to stabilize after Tuesday’s pullback, but the tape is now balancing AI strength, earnings delivery and a still-unsettled Middle East backdrop

Markets head into Wednesday after a weaker Tuesday session that showed how fragile this rally becomes when geopolitical stress returns late in the day. The broader setup is no longer one of effortless upside. AI and earnings still provide strong support, and stock futures improved again overnight after the U.S. extended the Iran ceasefire, but the market is also dealing with oil that remains elevated and a Strait of Hormuz situation that is not fully normalized. That means leadership still matters, earnings reactions matter even more, and the next move likely depends on whether strong results can keep offsetting a macro backdrop that remains unstable rather than fully resolved.

Top Stock-Specific Stories
  • NVDA / AMD / AVGO / TSM / ASML— The AI chain remains the market’s core leadership group, but expectations are now high enough that guidance quality matters as much as the headline numbersAI
  • TSLA— Tesla is one of the session’s biggest sentiment events, with Q1 results due after the close and the market focused on margins, pricing, energy and the autonomy narrativeEarnings
  • BA— Boeing is a key industrial read-through today as investors gauge whether execution and delivery recovery can keep supporting the cyclical side of the tapeIndustrial
  • AAPL— Apple is back in focus after the company named John Ternus as CEO to succeed Tim Cook, adding another layer to leadership and mega-cap narrative watchMega Cap
  • AAL / DAL / UAL / RCL / CCL— Travel remains highly sensitive to oil and consumer resilience, making the group an immediate read-through on whether energy pressure starts biting againTravel
  • XOM / CVX / BP / SHEL— Energy still acts as the macro swing pocket, with crude near triple digits keeping inflation and rotation risk aliveEnergy
Macro & Tape Pressure
  • Tuesday Proved the Rally Is Vulnerable to Headlines— The market gave back early gains as Middle East worries resurfaced into the closeIndex
  • The Rally Still Needs Earnings Confirmation— AI optimism is helping, but valuations now require continued delivery rather than just narrative supportEarnings
  • Oil Is Still Too High to Ignore— Even with the ceasefire extension, crude remains elevated enough to keep inflation and rotation concerns activeOil
  • The Ceasefire Helped, but It Did Not Fully Solve the Setup— The extension improved sentiment, yet the regional backdrop is still unstable and the Strait issue is not truly behind the marketGeo
  • Positioning Is No Longer Defensive— After the sharp rebound into record territory, downside sensitivity is higher when headlines or guidance disappointFlow
  • Breadth Improved, but Leadership Still Sits with a Few Names— The tape continues to lean heavily on large-cap tech and AI-linked winnersBreadth
Themes & Rotation
  • AI Still Carries the Bull Case— The strongest upside narrative remains tied to AI infrastructure, semis and related capex demandTheme
  • Rotation Can Flip Quickly— Energy, travel, industrials and mega-cap growth are all moving more directly off oil, earnings and geopolitical headlinesRotation
  • Selectivity Is Rising Again— The market is rewarding genuine execution and punishing anything that hints at softer demand or weaker marginsFlow
  • Macro Is Mixed, Not Cleanly Supportive— Ceasefire relief helps, but oil and geopolitics still limit how comfortable investors can getMacro
  • This Remains a Validation Phase— The market is still near highs, but it now needs real confirmation from earnings and leadership quality to keep extendingRisk
Tickers to Watch
  • NVDA / AMD / TSM / ASML— AI leadership confirmation remains the most important structural signal in the marketToday
  • TSLA— The most closely watched earnings catalyst of the day, with reaction likely to spill across growth and sentimentToday
  • BA— Major cyclical and industrial check-in for real economy confidenceToday
  • XOM / CVX— Key for monitoring whether crude keeps feeding the energy trade or starts easing more decisivelyEnergy
  • AAL / DAL— Immediate read-through on how oil pressure is being digested by travel-sensitive namesTravel
  • VIX / DXY / 10Y / Oil— Cross-asset confirmation remains essential because macro is still steering short-term risk appetiteMacro
Tape Watch
  • Earnings Reactions Matter More Than Headline Beats— Guidance quality and market expectations are doing most of the price-setting work nowEarnings
  • AI Leadership Sustainability— The key question is whether buyers keep pressing the same winners or begin rotating out after the big reboundSemis
  • Oil Direction After the Ceasefire Extension— A calmer crude tape would help equities; renewed spikes would quickly reintroduce pressureOil
  • Behavior Near High Levels— The market now needs to show it can absorb bad headlines without losing trend supportIndex
  • Geopolitical Headline Risk Is Still Live— The ceasefire extension improved tone, but the Middle East backdrop remains a real swing factor for the tapeGeo
Read the full Daily Briefing
Free Course

Run-Up Biotech Masterclass

Learn how to read biotech catalysts, trial results and FDA decisions with a practical framework.

Open
Educational only.
 Tracking Tool

Biotech Catalyst Calendar

Track FDA events, clinical readouts and biotech catalysts with a practical event-driven tool.

Open Archive

Browse the Blog & Archive

Explore articles, biotech deep dives, market notes, reports and archived sector content.

Open Reality Check

Biotech Trading Without the Fairy Tales

A grounded piece on risk, catalysts, dilution, volatility and biotech trading reality.

Open 2026 Watchlist

The New Era – Space, Defense & AI

A thematic watchlist built around military spending, strategic technology and AI-linked trends.

Open Briefing

SPACE AI DEFENCE

A thematic briefing at the intersection of defense, space infrastructure and AI.

Open Top List

Top 10 Defense-Tech Stocks to Watch

A focused list built around defense technology, drones and strategic systems.

Open Top List

Top 5 U.S. Airlines Watchlist

A practical watchlist for pricing power, fuel sensitivity, travel demand and macro tone.

Open Top List

Top 5 Cruise Lines Watchlist

A leisure-focused list centered on major cruise operators and pricing-driven sentiment.

Open
Scanner for active traders

Try ChartsWatcher free, then unlock 10% OFF with SAVE10

ChartsWatcher is a real-time scanner for momentum traders: fast movers, unusual volume and sector rotations — so you can focus on the few tickers that matter right now, instead of watching hundreds of charts.

Start with the free version. When you upgrade, use SAVE10 to get 10% OFF your first paid period.

Start free – then use SAVE10

No credit card required to start. Apply SAVE10 when upgrading.

ChartsWatcher platform screenshot
Recommended platform

One platform. All your brokers.

Medved Trader connects multiple brokers in one workspace, with professional charts, hotkeys and fast execution — without changing your broker accounts.

A single cockpit for positions, Level II and multi-broker order routing, built for active day and swing traders.

Get 1 Month Free ➔

Multi-broker workflow + customizable layouts in one platform.

Medved Trader platform dashboard
Monica.im Monica.im – the AI assistant I use every day
If you find value in the work I publish on Merlintrader and want a practical AI assistant for research and writing, you can sign up using this referral link. Click here to try Monica.im and support the site

Find out how I use AI on Merlintrader: AI, retail and Merlintrader

Disclosure: some of the links in the promotional blocks above are affiliate or referral links. If you choose to subscribe or sign up through them, Merlintrader may receive a small commission or benefit at no extra cost to you.

Merlintrader author

Authors: Merlintrader, Jane and Gemini

Author’s note

In every report I share what I see and how I personally interpret it, based on raw data from official company filings, regulatory documents, conference call transcripts and other primary sources where available. Some parts of the research and structure are supported by AI assistants, which help me organize the data, re-check details and improve charts or visual elements. However, any interpretation, opinion and final judgment remain entirely mine, as a trader and not as a licensed financial advisor or registered analyst. Market sentiment can change quickly, while official documents and numbers remain what they are. It is also possible for me to make mistakes: collecting and cross-checking FDA timelines, clinical data, filings and corporate updates is a complex job, so inaccuracies may occur. If you notice something that seems off, feel free to tell me and I will correct it. Please do not treat this report as professional investment advice, but as one more source of information to compare with your own research and with the opinion of qualified professionals.

AI usage disclosure

This report has been prepared using a human + AI workflow. Drafting, editing and data organization are supported by generative AI tools, such as large language models provided by third parties, based on prompts and instructions defined by the author. All sources used are public, and the final selection of data, checks, opinions and conclusions remains with the author, who takes full responsibility for the content.

If you find these reports useful and want to support the project, you can make a voluntary one-time donation via PayPal or Buy Me a Coffee. It helps cover data, tools and hosting costs, so the content can remain independent and freely accessible.

Buy Me a Coffee

Biotech Catalyst Calendar

For a broader and continuously updated view of upcoming biotech catalysts — PDUFA dates, major clinical readouts, regulatory events and key conferences — you can visit the dedicated calendar on Merlintrader.

Open the Biotech Catalyst Calendar